Cargando…

P391: PROGNOSTIC ANALYSIS OF RELAPSED PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA TREATED BY CCLG-ALL2008 PROTOCOL IN CHINA

Detalles Bibliográficos
Autores principales:	Wang, Ning, Chen, Xiao-Juan, Zhu, Xiao-Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429426/ http://dx.doi.org/10.1097/01.HS9.0000968472.48671.02

Ejemplares similares

E2A-PBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol
por: Hu, Yixin, et al.
Publicado: (2016)

Infections During Induction Therapy of Protocol CCLG-2008 in Childhood Acute Lymphoblastic Leukemia: A Single-center Experience with 256 Cases in China
por: Li, Si-Dan, et al.
Publicado: (2015)

Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study
por: Zheng, Huyong, et al.
Publicado: (2021)

Clinical-biological characteristics and treatment outcomes of pediatric pro-B ALL patients enrolled in BCH-2003 and CCLG-2008 protocol: a study of 121 Chinese children
por: Gao, Chao, et al.
Publicado: (2019)

Pericardial Relapse of Acute Lymphoblastic Leukemia (ALL)
por: Maslov, Diana V., et al.
Publicado: (2021)

P394: FRONTLINE COMBINATION OF OLVEREMBATINIB AND PDT-ALL-2016 PEDIATRIC INSPIRED PROTOCOL IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
por: Zhu, Kaibo, et al.
Publicado: (2023)

CCLG-2008方案治疗424例儿童急性淋巴细胞白血病的疗效分析
Publicado: (2017)

Pulmonary embolism in acute lymphoblastic leukemia — An observational study of 1685 patients treated according to the NOPHO ALL2008 protocol
por: Tuckuviene, Ruta, et al.
Publicado: (2020)

P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS
por: Baruchel, André, et al.
Publicado: (2023)

P1702: IMPACT OF CENTER CHARACTERISTICS AND MACROECONOMIC FACTORS ON THE OUTCOME OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC-INSPIRED PROTOCOLS
por: Barba, P., et al.
Publicado: (2022)

P386: COMPARISON OF THE PHARMACOKINETICS OF THE LIQUID AND THE LYOPHILIZED FORMULATIONS OF PEGASPARGASE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
por: Karachunskiy, Alexander, et al.
Publicado: (2023)

The prognostic potential of coilin in association with p27 expression in pediatric acute lymphoblastic leukemia for disease relapse
por: Yue, Zhi-Xia, et al.
Publicado: (2018)

P336: PREDICTIVE SCORES FOR RELAPSE AND PROGRESSION DISEASE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS BASED ON OPTICAL GENOME MAPPING TECHNOLOGY
por: Garcia Martinez, Jorge, et al.
Publicado: (2023)

P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL)
por: Ghobadi, Armin, et al.
Publicado: (2023)

Changes in body mass index during treatment of childhood acute lymphoblastic leukemia with the Nordic ALL2008 protocol
por: Egnell, Christina, et al.
Publicado: (2022)

Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol
por: Li, Xin-Yu, et al.
Publicado: (2021)

P396: FIFTEEN YEARS OF RUSSIAN RESEARCH IN THE TREATMENT OF ADULT PATIENTS WITH ACUTE PH-NEGATIVE LYMPHOBLASTIC LEUKEMIA ACCORDING TO THE PROTOCOLS ALL-2009 AND ALL-2016.
por: Aleshina (Gavrilina), Olga, et al.
Publicado: (2023)

CCLG-ALL-2008方案治疗ETV6-RUNX1融合基因阳性儿童急性淋巴细胞白血病：单中心长期随访结果
Publicado: (2020)

P348: GENOMIC CHARACTERIZATION OF RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PEDIATRIC PATIENTS UNDERGOING CAR-T TREATMENT IN A SINGLE CENTER
por: Esperanza Cebollada, Elena, et al.
Publicado: (2023)

P368: GENOMIC LANDSCAPE OF PEDIATRIC ACUTE B LYMPHOBLASTIC LEUKEMIA IN CHINA
por: Gao, Yangyang, et al.
Publicado: (2023)

P340: IN SEARCH FOR GENOMIC AND TRANSCRIPTOMIC PREDICTORS OF RELAPSE IN PEDIATRIC T-ALL
por: Dawidowska, Małgorzata, et al.
Publicado: (2023)

P388: THERAPY OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON PEDIATRIC-INSPIRED PROTOCOLS IN THE CZECH REPUBLIC IN 2007–2020
por: Salek, Cyril, et al.
Publicado: (2023)

Prognostic significance of steroid response in pediatric acute lymphoblastic leukemia: The CCCG-ALL-2015 study
por: Chu, Jinhua, et al.
Publicado: (2022)

Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP‐BFM acute lymphoblastic leukemia protocol
por: Jung, Mareike, et al.
Publicado: (2020)

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
por: Bhojwani, Deepa, et al.
Publicado: (2018)

Outcome of Adolescents with Acute Lymphoblastic Leukemia Treated by Pediatrics versus Adults Protocols
por: Ibrahim, Abeer, et al.
Publicado: (2014)

P377: A PHASE II TRIAL OF MINI-HYPER-CVD WITH VENETOCLAX FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) PHILADELPHIA CHROMOSOME (PH)-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
por: Haddad, Fadi, et al.
Publicado: (2023)

Skeletal abnormalities detected by SPECT is associated with increased relapse risk in pediatric acute lymphoblastic leukemia
por: Zhou, Fen, et al.
Publicado: (2017)

391. Outcomes of Empiric Antimicrobial Therapy in COVID-19 Positive Patients
por: Medler, Corey J, et al.
Publicado: (2020)

Prognostic factors and treatment of pediatric acute lymphoblastic leukemia
por: Lee, Jae Wook, et al.
Publicado: (2017)

P398: HIGH-RISK CHILDHOOD AND ADOLESCENT AND YOUNG ADULTS ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH THE EORTC 58951 PROTOCOL: RESULTS AND OUTCOME
por: Frikha, Imen, et al.
Publicado: (2023)

Testicular relapse of acute lymphoblastic leukemia()
por: Carolan, Alexandra, et al.
Publicado: (2023)

P1709: FERTILITY PRESERVATION FOR YOUNG ADULT ACUTE LYMPHOBLASTIC LEUKEMIAS IN ITALY: A CAMPUS ALL SURVEY.
por: Giglio, F., et al.
Publicado: (2022)

P1383: EXTRAMEDULLARY RELAPSE OF ACUTE MYELOID LEUKEMIA AND ACUTE LYMPHOBLASTIC LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION - A SINGLE-CENTER EXPERIENCE
por: Vasconcelos, F., et al.
Publicado: (2022)

P375: INOTUZUMB OZOGAMICIN PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY ACUTE B-LYMPHOBLASTIC LEUKEMIA
por: Kayser, Sabine, et al.
Publicado: (2023)

Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
por: Bhojwani, Deepa, et al.
Publicado: (2019)

Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia
por: Verneris, Michael R., et al.
Publicado: (2021)

Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia
por: Wang, Han, et al.
Publicado: (2023)

Rapid Molecular Response to Dasatinib in a Pediatric Relapsed Acute Lymphoblastic Leukemia With NCOR1-LYN Fusion
por: Dai, Hai-Ping, et al.
Publicado: (2020)

P573: NOVEL PROGNOSTIC MODEL FOR RELAPSE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Wen, Qi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4o28h2r0euv41289qm1ht8hf3k